Jianghong Yu

997 total citations
25 papers, 740 citations indexed

About

Jianghong Yu is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Jianghong Yu has authored 25 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Jianghong Yu's work include Liver Disease Diagnosis and Treatment (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Hepatitis B Virus Studies (3 papers). Jianghong Yu is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Hepatitis B Virus Studies (3 papers). Jianghong Yu collaborates with scholars based in China and United States. Jianghong Yu's co-authors include Lisa Francis, András Perl, Hajra Tily, Ádám Bartos, Ricardo Garcı́a, Paul E. M. Phillips, Maha Dawood, Stephen V. Faraone, Zhi‐Wei Lai and Eduardo Bonilla and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Cancer Research.

In The Last Decade

Jianghong Yu

21 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianghong Yu China 10 320 263 236 108 108 25 740
Lan Shao China 16 371 1.2× 324 1.2× 162 0.7× 87 0.8× 163 1.5× 27 892
Niki Karagianni Greece 13 263 0.8× 250 1.0× 94 0.4× 140 1.3× 42 0.4× 30 687
Zhuochun Huang China 16 434 1.4× 334 1.3× 323 1.4× 221 2.0× 51 0.5× 54 1.0k
Anja Meyer Germany 17 301 0.9× 185 0.7× 107 0.5× 56 0.5× 62 0.6× 30 748
Devi Ngo Australia 15 419 1.3× 206 0.8× 65 0.3× 64 0.6× 47 0.4× 16 700
Vishala Chindalore United States 10 420 1.3× 167 0.6× 484 2.1× 32 0.3× 35 0.3× 17 835
Michael Binks United Kingdom 18 246 0.8× 250 1.0× 392 1.7× 32 0.3× 32 0.3× 29 941
Hiroto Ishikura Japan 12 256 0.8× 275 1.0× 85 0.4× 41 0.4× 46 0.4× 25 705
Chun Deng China 12 269 0.8× 454 1.7× 123 0.5× 108 1.0× 28 0.3× 20 804
Yuwen Su China 12 592 1.9× 323 1.2× 83 0.4× 141 1.3× 55 0.5× 25 900

Countries citing papers authored by Jianghong Yu

Since Specialization
Citations

This map shows the geographic impact of Jianghong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianghong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianghong Yu more than expected).

Fields of papers citing papers by Jianghong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianghong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianghong Yu. The network helps show where Jianghong Yu may publish in the future.

Co-authorship network of co-authors of Jianghong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianghong Yu. A scholar is included among the top collaborators of Jianghong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianghong Yu. Jianghong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Jianghong, et al.. (2025). Myeloid Glutamine Synthetase Protects Against Acute Liver Injury in Mice Independent of Its Enzyme Activity. Liver International. 45(7). e70105–e70105.
4.
5.
Lin, Hongbing, Jinbin Liu, Juan Hong, et al.. (2024). Microneedle patch with pure drug tips for delivery of liraglutide: pharmacokinetics in rats and minipigs. Drug Delivery and Translational Research. 15(1). 216–230. 9 indexed citations
6.
Zhang, Hui‐Lu, Ping Chen, He‐Xin Yan, et al.. (2022). Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine Starvation. Advanced Science. 9(20). e2103887–e2103887. 28 indexed citations
7.
Ma, Liyun, Jianghong Yu, Bing Zhao, et al.. (2022). Effects of Immune Cells on Intestinal Stem Cells: Prospects for Therapeutic Targets. Stem Cell Reviews and Reports. 18(7). 2296–2314. 8 indexed citations
8.
Yu, Jianghong, et al.. (2022). Appraising SARS-CoV-2 infections after full mRNA COVID-19 vaccination in patients with systemic lupus erythematosus (SLE). SHILAP Revista de lepidopterología. 2. 54–56.
9.
Ding, Hao, et al.. (2021). RASAL2 Deficiency Attenuates Hepatic Steatosis by Promoting Hepatic VLDL Secretion via the AKT/TET1/MTTP Axis. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 3 indexed citations
10.
Yu, Jianghong, et al.. (2021). Protective Effects of Aminooxyacetic Acid on Colitis Induced in Mice with Dextran Sulfate Sodium. BioMed Research International. 2021(1). 1477345–1477345. 7 indexed citations
11.
Yu, Jianghong, et al.. (2020). Geriatric Rheumatology: The Need for a Separate Subspecialty in the Near Future. Cureus. 12(6). e8474–e8474. 3 indexed citations
12.
Dong, Qijuan, et al.. (2019). Application value of whole hospital blood glucose management to non department of endocrinology inpatients. 125–129. 1 indexed citations
13.
Zhu, Jie, Zhongguang Luo, Yida Pan, et al.. (2018). H19/miR‐148a/USP4 axis facilitates liver fibrosis by enhancing TGF‐β signaling in both hepatic stellate cells and hepatocytes. Journal of Cellular Physiology. 234(6). 9698–9710. 84 indexed citations
14.
Zhu, Jie, Ziqiang Zhang, Yitong Zhang, et al.. (2018). MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7. Biochemical and Biophysical Research Communications. 496(1). 176–183. 28 indexed citations
15.
Zhang, Ziqiang, Jie Zhu, Yuanqiang Dong, et al.. (2017). Global transcriptome-wide analysis of the function of GDDR in acute gastric lesions. Molecular Medicine Reports. 16(6). 8673–8684. 3 indexed citations
16.
Zhang, Jingying, Lin Chen, Han Yu, et al.. (2017). Gene identification of rare B(A) blood group. Transfusion and Apheresis Science. 56(6). 855–857. 5 indexed citations
17.
Yu, Jianghong, et al.. (2016). Gene analysis of two cases with CisAB/B blood subgroup. Transfusion and Apheresis Science. 56(2). 223–225. 2 indexed citations
18.
Liu, Yuxin, Jianghong Yu, Zachary Oaks, et al.. (2015). Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus. Clinical Immunology. 160(2). 319–327. 29 indexed citations
19.
Lai, Zhi‐Wei, Ashwini Shadakshari, Jianghong Yu, et al.. (2014). mTOR activation triggers proinflammatory expansion of IL-4-producing and necrosis-prone double-negative T cells, precedes flares, and serves as target for treatment in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 16(Suppl 1). A25–A25. 1 indexed citations
20.
Lai, Zhi‐Wei, Robert Hanczko, Eduardo Bonilla, et al.. (2012). N ‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial. Arthritis & Rheumatism. 64(9). 2937–2946. 328 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026